The prognostic significance of clinical and pathological features in hepatocellular carcinoma (Q34582844)

3 August 2017

1 reference

title

The prognostic significance of clinical and pathological features in hepatocellular carcinoma (English)

1 reference

3 August 2017

Lun-Xiu Qin

1

1 reference

PubMed ID

11925590

3 August 2017

Zhao-You Tang

series ordinal

2

1 reference

PubMed ID

11925590

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

World Journal of Gastroenterology

3 August 2017

1 reference

3 August 2017

8

1 reference

3 August 2017

2

1 reference

3 August 2017

193-199

1 reference

Liver resection for cancer

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Hepatocellular carcinoma--cause, treatment and metastasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

The value of postoperative hepatic regional chemotherapy in prevention of recurrence after radical resection of primary liver cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Hepatocellular carcinoma in central Sydney:a 10-year review of patients seen in a medical oncology department

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Relationship between expression of alpha-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Hepatocellular carcinoma: current surgical management

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

7 July 2018

Cancer statistics, 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Resection of hepatocellular carcinoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Prediction of recurrence and extratumor spread of hepatocellular carcinoma following resection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Hepatocellular carcinoma in Central Europe: prognostic features and survival

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Estimates of the worldwide mortality from 25 cancers in 1990.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Progress in research of liver surgery in China.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Preoperative administration of 5-FU and interferon beta may prevent recurrence of hepatitis B and C virus

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Transcatheter arterial chemoembolization for postoperative residual tumor of hepatocellular carcinoma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Prophylactic chemolipiodolization for postoperative hepatoma patients

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Influence of previous interferon therapy on recurrence after resection of hepatitis c virus-related hepatocellular carcinoma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Preoperative main portal branch transection combined with liver locoregional transarterial neo and adjuvant immunochemotherapy for patients with hepatocellular carcinoma.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Clinicopathologic study on hepatocellular carcinoma negative for hepatitis B surface antigen and antibody to hepatitis C virus

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Correlation of clinicopathologic features of resected hepatocellular carcinoma with hepatitis C virus genotype

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Retrospective analysis of type of hepatic resection for hepatocellular carcinoma.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4658349

Hepatic resection for hepatocellular carcinoma

27 October 2018

1 reference

12 December 2020

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization

1 reference

12 December 2020

The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma

1 reference

12 December 2020

Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival

1 reference

12 December 2020

Hepatic function immediately after hepatectomy as a significant risk factor for early recurrence in hepatocellular carcinoma

1 reference

12 December 2020

[Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence]

1 reference

12 December 2020

Clinicopathologic features and postoperative prognosis of multicentric small hepatocellular carcinoma

1 reference

12 December 2020

Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function

1 reference

12 December 2020

Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis

1 reference

12 December 2020

Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial

1 reference

12 December 2020

What patients can survive disease free after complete resection for hepatocellular carcinoma?: A multivariate analysis

1 reference

12 December 2020

Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma

1 reference

12 December 2020

Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study

1 reference

12 December 2020

Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma

1 reference

12 December 2020

Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis

1 reference

12 December 2020

Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma

1 reference

12 December 2020

Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma

1 reference

12 December 2020

Extent of hepatic resection as a prognostic factor for small, solitary hepatocellular carcinomas

1 reference

12 December 2020

Clinical significance of alpha-fetoprotein mRNA during perioperative period in HCC

1 reference

12 December 2020

Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation

1 reference

12 December 2020

Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study

1 reference

12 December 2020

The clinical significance of lymph node metastases in patients undergoing surgery for hepatocellular carcinoma

1 reference

12 December 2020

Surgical results in patients with hepatitis B-related hepatocellular carcinoma and positive hepatitis B early antigen

1 reference

12 December 2020

Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma

1 reference

12 December 2020

Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection

1 reference

12 December 2020

Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors

1 reference

12 December 2020

Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery

1 reference

12 December 2020

Surgical outcome in cirrhotic patients with hepatitis C-related hepatocellular carcinoma

1 reference

12 December 2020

Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma

1 reference

12 December 2020

Evaluation of a simplified staging system for prognosis of hepatocellular carcinoma

1 reference

12 December 2020

Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma

1 reference

12 December 2020

Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up

1 reference

12 December 2020

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

12 December 2020

Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma

1 reference

12 December 2020

Evaluation of major hepatic resection for small hepatocellular carcinoma

1 reference

12 December 2020

How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system

1 reference

12 December 2020

High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential

1 reference

12 December 2020

Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma

1 reference

12 December 2020

Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma

1 reference

12 December 2020

Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma

1 reference

12 December 2020

Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival

1 reference

12 December 2020

The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma

1 reference

12 December 2020

Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis

1 reference

12 December 2020

Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy

1 reference

12 December 2020

Factors regulating tumor pressure in hepatocellular carcinoma and implications for tumor spread

1 reference

12 December 2020

Efficacy of major hepatic resection for large hepatocellular carcinoma

1 reference

12 December 2020

Morphology and other prognostic factors of hepatocellular carcinoma

1 reference

12 December 2020

Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases

1 reference

12 December 2020

Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V8.I2.193

0 references

PMCID

4658349

1 reference

3 August 2017

1 reference

PubMed ID

11925590